Replies to post #147697 on SMART MONEY GROUP

[Buyfor1sell for2]

ONCY - Oncolytics Biotech Doses First Patient in Phase 2 IRENE Study Evaluating Pelareorep-anti-PD-1 Combination Treatment in Triple-Negative Breast Cancer
[7:00 AM]

[TheFinalCD]

XSPA 2.56 offering




ugh~!